Ke Jian Liu

Title: Ke Jian Liu: Innovator in Blood Brain Barrier Research

Introduction

Ke Jian Liu is a prominent inventor based in Albuquerque, NM (US). He has made significant contributions to the field of medical research, particularly in understanding and treating blood brain barrier (BBB) disruptions. With a total of five patents to his name, Liu's work is paving the way for advancements in ischemic stroke treatment.

Latest Patents

One of Liu's latest patents focuses on a blood biomarker for early detection of blood brain barrier disruption in ischemic stroke. The methods and apparatus he developed involve detecting the presence of cleaved occludin fragments in a blood sample. This innovative approach allows for determining the degree of BBB damage based on the concentration of occludin fragments present. Additionally, the patent includes the provision of kits designed for detecting these fragments in blood samples, enhancing the potential for timely medical intervention.

Career Highlights

Throughout his career, Ke Jian Liu has worked with notable organizations such as the Science and Technology Corporation at the University of New Mexico. His research has been instrumental in advancing the understanding of BBB damage and its implications for ischemic events.

Collaborations

Liu has collaborated with esteemed colleagues, including Wenlan Liu and Graham Timmins, contributing to a rich exchange of ideas and expertise in his field.

Conclusion

Ke Jian Liu's innovative work in the realm of blood brain barrier research exemplifies the impact of dedicated inventors in the medical field. His patents not only enhance our understanding of ischemic stroke but also provide practical solutions for early detection and treatment.